Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.

IF 2.7 4区 医学 Q2 UROLOGY & NEPHROLOGY
Claudia D'Alessandro, Domenico Giannese, Giorgina Barbara Piccoli, Vincenzo Panichi, Adamasco Cupisti
{"title":"Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.","authors":"Claudia D'Alessandro, Domenico Giannese, Giorgina Barbara Piccoli, Vincenzo Panichi, Adamasco Cupisti","doi":"10.1007/s40620-025-02285-7","DOIUrl":null,"url":null,"abstract":"<p><p>Over the last few decades, there has been growing interest in the use of ketogenic diets, mainly as a weight loss strategy. Obesity and diabetes are major risk factors for kidney disease, and obese patients with chronic kidney disease (CKD) are potential candidates for weight reducing diets, among them ketogenic diets. Of further relevance to nephrology, a limited number of recent studies suggests a favorable effect of ketogenic diets in patients affected by autosomal dominant polycystic kidney disease (ADPKD). However, concerns remain about safety in patients with CKD, particularly in the long term and in those with poor residual kidney function. The confusion surrounding the definition of ketogenic diets adds to these concerns. The aim of this review is to summarize information on the main types of ketogenic diets used in daily practice and to discuss the options for their implementation in CKD patients, limiting ultra-processed or industrial preparations.Although further studies are needed to identify the profile of CKD patients who may benefit from the implementation of ketogenic diets to treat obesity or slow the progression of ADPKD, and to assess short- and long-term safety and adherence, the available data appear promising. This critical review is intended to stimulate further research.</p>","PeriodicalId":16542,"journal":{"name":"Journal of Nephrology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40620-025-02285-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Over the last few decades, there has been growing interest in the use of ketogenic diets, mainly as a weight loss strategy. Obesity and diabetes are major risk factors for kidney disease, and obese patients with chronic kidney disease (CKD) are potential candidates for weight reducing diets, among them ketogenic diets. Of further relevance to nephrology, a limited number of recent studies suggests a favorable effect of ketogenic diets in patients affected by autosomal dominant polycystic kidney disease (ADPKD). However, concerns remain about safety in patients with CKD, particularly in the long term and in those with poor residual kidney function. The confusion surrounding the definition of ketogenic diets adds to these concerns. The aim of this review is to summarize information on the main types of ketogenic diets used in daily practice and to discuss the options for their implementation in CKD patients, limiting ultra-processed or industrial preparations.Although further studies are needed to identify the profile of CKD patients who may benefit from the implementation of ketogenic diets to treat obesity or slow the progression of ADPKD, and to assess short- and long-term safety and adherence, the available data appear promising. This critical review is intended to stimulate further research.

生酮饮食对慢性肾病患者的影响:怀疑者对怀疑者的评论。
在过去的几十年里,人们对使用生酮饮食越来越感兴趣,主要是作为一种减肥策略。肥胖和糖尿病是肾脏疾病的主要危险因素,慢性肾脏疾病(CKD)的肥胖患者是减肥饮食的潜在候选者,其中包括生酮饮食。与肾病学进一步相关的是,最近有限数量的研究表明生酮饮食对常染色体显性多囊肾病(ADPKD)患者有良好的影响。然而,对CKD患者的安全性仍然存在担忧,特别是长期和残余肾功能不佳的患者。围绕生酮饮食定义的困惑增加了这些担忧。本综述的目的是总结日常实践中使用的主要生酮饮食类型的信息,并讨论在CKD患者中实施的选择,限制超加工或工业制剂。虽然需要进一步的研究来确定可能受益于实施生酮饮食治疗肥胖或减缓ADPKD进展的CKD患者的概况,并评估短期和长期的安全性和依从性,但现有的数据似乎很有希望。这篇批评性的综述旨在促进进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Nephrology
Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
5.60
自引率
5.90%
发文量
289
审稿时长
3-8 weeks
期刊介绍: Journal of Nephrology is a bimonthly journal that considers publication of peer reviewed original manuscripts dealing with both clinical and laboratory investigations of relevance to the broad fields of Nephrology, Dialysis and Transplantation. It is the Official Journal of the Italian Society of Nephrology (SIN).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信